We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Respiratory Effects of Algal Toxins

By Biotechdaily staff writers
Posted on 01 Dec 2004
Researchers seeking new drugs to treat the mucus build-up associated with cystic fibrosis and similar lung diseases have isolated a compound from the red tide alga Karenia brevis that has a powerful positive effect on the flow of mucus through the respiratory tract.

The red tide toxic algal blooms are caused by several genera of dinoflagellates, which turn the sea red and are frequently associated with deterioration in water quality. More...
The color occurs as a result of the reaction of a red pigment, peridinin, to light during photosynthesis. These toxic algal blooms pose a serious threat to marine life and are potentially harmful to humans. In particular, particles containing toxins become aerosolized by the action of wind and waves and cause irritation of the eyes, nose, throat, lips, and tongue.

Investigators at Mount Sinai Medical Center (Miami, FL, USA) and University of North Carolina's Center for Marine Science (Wilmington, USA) studied compounds produced by K brevis in order to identify those affecting the respiratory tract. They found three active toxins and one compound, brevenal, which was shown to have a beneficial effect on the respiratory tract. Additionally, a synthetic compound, beta-naphthoyl-brevetoxin, was produced that worked in a similar fashion to brevenal.

"We found these compounds are able to speed up the clearance of mucus from the lungs,” said senior author Dr. Daniel Baden, director of the University of North Carolina's Center for Marine Science. "These compounds will serve as experimental models in the development of drug therapies for those who suffer from cystic fibrosis and other lung disorders characterized by excessive mucus secretion.”

These findings were published in the September 24, 2004, online edition of the American Journal of Respiratory and Critical Care Medicine.

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Thyroid Test
Anti-Thyroid EIA Test
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.